Christopher Joos1, Kevin Lawrence1, Aubrey E Jones2, Stacy A Johnson3, Daniel M Witt4. 1. Department of Pharmacotherapy, University of Utah College of Pharmacy, 30 South 2000 East, Salt Lake City, UT 84112, United States. 2. Department of Pharmacotherapy, University of Utah College of Pharmacy, 30 South 2000 East, Salt Lake City, UT 84112, United States; Thrombosis Service, University of Utah Hospital, 50 North Medical Drive Room 1R211, Salt Lake City, UT 84132, United States. 3. Department of Internal Medicine, University of Utah School of Medicine, 30 North 1900 East, Rm 5R218, Salt Lake City, UT 84132, United States. 4. Department of Pharmacotherapy, University of Utah College of Pharmacy, 30 South 2000 East, Salt Lake City, UT 84112, United States; Thrombosis Service, University of Utah Hospital, 50 North Medical Drive Room 1R211, Salt Lake City, UT 84132, United States. Electronic address: dan.witt@pharm.utah.edu.
Abstract
INTRODUCTION: Administratively coded data are frequently used in observational research to identify outcome events. With the transition to the new International Classification of Diseases coding system's 10th version (ICD-10), information is needed about the coding accuracy for bleeding events in anticoagulated patients. We aimed to determine ICD-10 code accuracy for bleeding events in anticoagulated patients admitted to the hospital. METHODS: This cross-sectional study retrospectively examined charts of anticoagulated patients who were admitted to the University of Utah Hospital between October 1, 2017 and December 31, 2017. Two trained chart abstractors blinded to ICD-10 code status independently reviewed medical charts to determine the presence or absence of bleeding events. ICD-10 code status in any diagnosis position was unblinded and code accuracy was assessed using sensitivity, specificity, positive predictive value (PPV), and negative predictive values (NPV) along with 95% confidence intervals (CI). RESULTS: Out of 661 admissions, 487 unique patients and 71 bleeding events were identified. Gastrointestinal tract bleeding and intracranial hemorrhage comprised 32.4% and 19.7% of bleeding events respectively. ICD-10 code sensitivity was 91.4% (95% CI, 82.3-96.8), specificity was 90.2% (87.5-92.5), PPV was 52.5% (43.2-61.6) and NPV 98.9% (97.6-99.6). Individual codes for intracranial hemorrhages and gastrointestinal tract bleeding had similar accuracy as the overall set of bleeding codes. CONCLUSIONS: Our results demonstrate that ICD-10 codes can reliably rule-out hospitalizations for bleeding events in patients receiving anticoagulation therapy. Due to unacceptable false positive rates ICD-10 codes should not be used for identifying bleeding complications without confirmatory chart review.
INTRODUCTION: Administratively coded data are frequently used in observational research to identify outcome events. With the transition to the new International Classification of Diseases coding system's 10th version (ICD-10), information is needed about the coding accuracy for bleeding events in anticoagulated patients. We aimed to determine ICD-10 code accuracy for bleeding events in anticoagulated patients admitted to the hospital. METHODS: This cross-sectional study retrospectively examined charts of anticoagulated patients who were admitted to the University of Utah Hospital between October 1, 2017 and December 31, 2017. Two trained chart abstractors blinded to ICD-10 code status independently reviewed medical charts to determine the presence or absence of bleeding events. ICD-10 code status in any diagnosis position was unblinded and code accuracy was assessed using sensitivity, specificity, positive predictive value (PPV), and negative predictive values (NPV) along with 95% confidence intervals (CI). RESULTS: Out of 661 admissions, 487 unique patients and 71 bleeding events were identified. Gastrointestinal tract bleeding and intracranial hemorrhage comprised 32.4% and 19.7% of bleeding events respectively. ICD-10 code sensitivity was 91.4% (95% CI, 82.3-96.8), specificity was 90.2% (87.5-92.5), PPV was 52.5% (43.2-61.6) and NPV 98.9% (97.6-99.6). Individual codes for intracranial hemorrhages and gastrointestinal tract bleeding had similar accuracy as the overall set of bleeding codes. CONCLUSIONS: Our results demonstrate that ICD-10 codes can reliably rule-out hospitalizations for bleeding events in patients receiving anticoagulation therapy. Due to unacceptable false positive rates ICD-10 codes should not be used for identifying bleeding complications without confirmatory chart review.
Authors: Luyu Xie; Andrew Gelfand; Matthew S Mathew; Folefac D Atem; Nimisha Srikanth; George L Delclos; Sarah E Messiah Journal: Drugs Real World Outcomes Date: 2022-06-08
Authors: Amber Afzal; Brian F Gage; Luo Suhong; Martin W Schoen; Kevin Korenblat; Kristen M Sanfilippo Journal: J Thromb Haemost Date: 2022-05-26 Impact factor: 16.036
Authors: Cezary Maciejewski; Krzysztof Ozierański; Mikołaj Basza; Piotr Lodziński; Andrzej Śliwczyński; Leszek Kraj; Maciej Janusz Krajsman; Jefte Prado Paulino; Agata Tymińska; Grzegorz Opolski; Andrzej Cacko; Marcin Grabowski; Paweł Balsam Journal: Int J Environ Res Public Health Date: 2022-09-22 Impact factor: 4.614